Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Liver Diseases

  Free Subscription


28.04.2025

2 BMC Cancer
7 BMC Gastroenterol
1 Br J Surg
2 Dig Dis Sci
2 Eur Radiol
1 Gastroenterology
5 Hepatology
1 Indian J Gastroenterol
2 J Gastroenterol
1 J Gastroenterol Hepatol
1 J Hepatol
1 PLoS Biol
1 PLoS One
1 Transplantation


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    BMC Cancer

  1. XIE Z, Dai Z, Liu Z, Chen Y, et al
    The impact of an RNA-binding protein group on regulating the RSPO-LGR4/5-ZNRF3/RNF43 module and the immune microenvironment in hepatocellular carcinoma.
    BMC Cancer. 2025;25:751.
    PubMed         Abstract available

  2. LEE SM, Choi JH, Yoon JH, Kim YJ, et al
    Efficacy and safety of image-guided hypofractionated radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis: a retrospective, multicenter study.
    BMC Cancer. 2025;25:736.
    PubMed         Abstract available


    BMC Gastroenterol

  3. WANG J, Shi J, Mi L, Li N, et al
    Identification and validation of a lenvatinib resistance-related prognostic signature in HCC, in which PFKFB4 contributes to tumor progression and lenvatinib resistance.
    BMC Gastroenterol. 2025;25:287.
    PubMed         Abstract available

  4. YANG L, Li J, Xie Y, Qian G, et al
    The non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio as a predictor of all cause and cardiovascular mortality in United States adults with NAFLD: a prospective cohort study.
    BMC Gastroenterol. 2025;25:288.
    PubMed         Abstract available

  5. HOSOI Y, Kawakami M, Ito D, Kamimoto T, et al
    Mapping of rehabilitation interventions and assessment methods for patients with liver cirrhosis: a scoping review.
    BMC Gastroenterol. 2025;25:291.
    PubMed         Abstract available

  6. WAN X, Xu H, Li H, Zhong S, et al
    Effectiveness and safety evaluation of terlipressin in the treatment of intestinal paralysis in end-stage liver disease.
    BMC Gastroenterol. 2025;25:286.
    PubMed         Abstract available

  7. LARSSON AL, Holka P, Isaksson B, Hemmingsson O, et al
    Translation and validation of the Swedish version of the EORTC LMC-21, the disease-specific questionnaire for assessing health-related quality of life in patients with colorectal liver metastases.
    BMC Gastroenterol. 2025;25:281.
    PubMed         Abstract available

  8. ZHOU B, Liu J, Jin L, Huang X, et al
    Remimazolam alleviates hepatic ischemia-reperfusion injury by activating FOXO1/3 signaling : Remimazolam alleviates hepatic ischemia reperfusion injury.
    BMC Gastroenterol. 2025;25:283.
    PubMed         Abstract available

  9. LI M, Wan Y, Wei Z, Lin W, et al
    Comparison of the predictive value of TyG index and METS-IR for OSA combined with NAFLD: a retrospective observational study based on a physical examination population.
    BMC Gastroenterol. 2025;25:279.
    PubMed         Abstract available


    Br J Surg

  10. WANG X, Liang J, Cao L, Liu Y, et al
    Laparoscopic in situ anatomical resection of posterosuperior liver segments: preservation of segment 6 regardless of the presence of the inferior right hepatic vein.
    Br J Surg. 2025;112:znaf066.
    PubMed        


    Dig Dis Sci

  11. ABUSULIMAN M, Dawod S, Nimri F, Jamali T, et al
    Predictive Factors of Post-ERCP Hepatic Decompensation in Patients with Cirrhosis: A Retrospective Case-Control Study.
    Dig Dis Sci. 2025 Apr 24. doi: 10.1007/s10620-025-09071.
    PubMed         Abstract available

  12. LU R, Abuduhailili X, Li Y, Wang S, et al
    Integrated Analysis of PSMB8 Expression and Its Potential Roles in Hepatocellular Carcinoma.
    Dig Dis Sci. 2025 Apr 22. doi: 10.1007/s10620-025-09040.
    PubMed         Abstract available


    Eur Radiol

  13. RUAN J, He Y, Li Q, Song M, et al
    CT feature of irregular extensive ulceration as a predictor of liver metastasis in gastric gastrointestinal stromal tumours.
    Eur Radiol. 2025;35:2759-2768.
    PubMed         Abstract available

  14. ALVES VPV, Mouzaki M, Xanthakos SA, Zhang B, et al
    Longitudinal evaluation of pediatric and young adult metabolic dysfunction-associated steatotic liver disease defined by MR elastography.
    Eur Radiol. 2025;35:2474-2486.
    PubMed         Abstract available


    Gastroenterology

  15. PEERY AF, Murphy CC, Anderson C, Jensen ET, et al
    Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2024.
    Gastroenterology. 2025 Feb 4:S0016-5085(25)00034.
    PubMed         Abstract available


    Hepatology

  16. FUJIWARA N, Matsushita Y, Tempaku M, Tachi Y, et al
    AI-based phenotyping of hepatic fiber morphology to inform molecular alterations in metabolic dysfunction-associated steatotic liver disease.
    Hepatology. 2025 Apr 22. doi: 10.1097/HEP.0000000000001360.
    PubMed         Abstract available

  17. FIX OK, Kane M, Gainey CS, Khairat S, et al
    Privacy and fidelity: The promise of synthetic data in hepatology research.
    Hepatology. 2025 Apr 21. doi: 10.1097/HEP.0000000000001361.
    PubMed        

  18. WANG J, Zhang S, Fan T, Wu C, et al
    Letter to the Editor: Association of hepatitis B surface antigen and risk of hepatocellular carcinoma in chronic hepatitis B patients with immune-tolerant phase.
    Hepatology. 2025 Apr 21. doi: 10.1097/HEP.0000000000001365.
    PubMed        

  19. HUI VW, Wong GL, Dai J, Tse YK, et al
    Increased risk of hepatocellular carcinoma in HBeAg-negative indeterminate phase compared to HBeAg-negative chronic infection.
    Hepatology. 2025 Apr 21. doi: 10.1097/HEP.0000000000001354.
    PubMed         Abstract available

  20. TSENG TC, Kao JH
    Reply: Association of hepatitis B surface antigen and risk of hepatocellular carcinoma in chronic hepatitis B patients with immune-tolerant phase.
    Hepatology. 2025 Apr 21. doi: 10.1097/HEP.0000000000001366.
    PubMed        


    Indian J Gastroenterol

  21. LEE JC, Chong JW, Rahman TM
    Bone mineral density trends in cirrhotic patients.
    Indian J Gastroenterol. 2025 Apr 24. doi: 10.1007/s12664-025-01780.
    PubMed        


    J Gastroenterol

  22. XIA M, Lu Y, Yin F, Cao Z, et al
    The external validation of Dallas Steatosis Index among Asian population: a useful tool for metabolic dysfunction-associated steatotic liver disease identification and prevention.
    J Gastroenterol. 2025;60:621-631.
    PubMed         Abstract available

  23. ZHANG Y, Che N, Wang S, Meng J, et al
    Correction: Nrf2/ASPM axis regulated vasculogenic mimicry formation in hepatocellular carcinoma under hypoxia.
    J Gastroenterol. 2025 Apr 23. doi: 10.1007/s00535-025-02246.
    PubMed        


    J Gastroenterol Hepatol

  24. LEE HA, Lee HW, Seo YS, Sinn DH, et al
    Risk of Hepatocellular Carcinoma Decreases After Antiviral Therapy-Induced HBsAg Seroclearance.
    J Gastroenterol Hepatol. 2025 Apr 24. doi: 10.1111/jgh.16973.
    PubMed         Abstract available


    J Hepatol

  25. JEONG S
    Significant Hepatic Fat Loss after Metabolic Dysfunction-associated Steatotic Liver Disease: Beware of Misclassification as Absence of Disease.
    J Hepatol. 2025 Apr 22:S0168-8278(25)00250-8. doi: 10.1016/j.jhep.2025.
    PubMed        


    PLoS Biol

  26. REGNIER M, Polizzi A, Fougeray T, Fougerat A, et al
    Liver gene expression and its rewiring in hepatic steatosis are controlled by PI3Kalpha-dependent hepatocyte signaling.
    PLoS Biol. 2025;23:e3003112.
    PubMed         Abstract available


    PLoS One

  27. TAKADA H, Osawa L, Komiyama Y, Muraoka M, et al
    Imaging-based assessment of muscles and malnutrition predict prognosis in patients with primary hepatocellular carcinoma.
    PLoS One. 2025;20:e0307458.
    PubMed         Abstract available


    Transplantation

  28. MALIK TH, Keeney E, Jang A, Hafeez MS, et al
    Is the Transplantation of Elderly and DCD Donors in Low MELD Recipients Justified: An Intent-to-treat Analysis.
    Transplantation. 2025;109:823-831.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.